« Previous  |  Next »

Mammogram Debate Shows Why Reform Will Fail

In the midst of the debate over health care reform, we have been handed the perfect example of why America will never get health care costs under control: The furious reaction to new guidelines that recommend most women should get mammograms later in ...

From ROBERT LANGRETH AND REBECCA RUIZ, Forbes,  19 Nov 2009

Related Topics: American Cancer Society,  U.S. Senate,  Harry Reid,  Washington Post Company,  White House

Too Many Mammograms

For years women have trekked to doctors' offices for annual mammograms starting at age 40. But a new study says this may not be necessary: Women can wait until age 50 for their first mammogram with little downside, and they only need to get the exams ...

From ROBERT LANGRETH, Forbes,  16 Nov 2009

Related Topics: American Cancer Society,  General Electric,  Georgetown University

Worse Than You Think

How much of the $2.5 trillion the U.S. spends on health care goes down the drain for tests and treatments that don't help, run up the bill and may even cause harm? When it comes to financial threats to the u.s., President Obama says nothing even comes ...

From ROBERT LANGRETH, Forbes,  12 Nov 2009

Related Topics: Barack Obama,  U.S. Congress,  American Medical Association,  University of California, Los Angeles

When to Say No to Your Doctor

When it comes to financial threats to our country, President Obama says nothing even comes close to spiraling health care costs, expected to hit $2.5 trillion this year. Legislators are struggling to come up with health reform plans that cover millions ...

From ROBERT LANGRETH, Forbes,  5 Nov 2009

Related Topics: Barack Obama,  U.S. Congress,  American Medical Association,  University of California, Los Angeles

Good Medicine: When to Say No to Your Doctor

When it comes to financial threats to our country, President Obama says nothing even comes close to spiraling health care costs, expected to hit $2.5 trillion this year. Legislators are struggling to come up with health reform plans that cover millions ...

From ROBERT LANGRETH, Forbes,  5 Nov 2009

Related Topics: Barack Obama,  U.S. Congress,  American Medical Association,  University of California, Los Angeles

Genomics: No Longer A Failure

Shares of Human Genome Sciences and Vertex Pharmaceuticals, tiny drug developers that first gained during the hype fest that followed the mapping of the human genetic code a decade ago, are soaring Monday morning after positive clinical trial ...

From MATTHEW HERPER AND ROBERT LANGRETH, Forbes,  2 Nov 2009

Related Topics: Human Genome Sciences, Inc.,  Food and Drug Administration,  J. Craig Venter,  GlaxoSmithKline Inc,  Johnson & Johnson

Amgen's Anemic Results

More bad news for Amgen and its beleaguered anemia drug franchise: A giant trial finds the company's Aranesp drug nearly doubles the risk of strokes in kidney disease patients. Aranesp sales have already been plummeting amid various safety problems, ...

From ROBERT LANGRETH, Forbes,  29 Oct 2009

Related Topics: Amgen Inc.,  New England Journal of Medicine,  Johnson & Johnson

Cancer Beats AstraZeneca

In a big setback for AstraZeneca, the British drugmaker withdrew its application for approval of its experimental lung cancer drug Zactima after new data from big trials showed that the drug did not extend the lives of lung cancer patients. Cancer is ...

From ROBERT LANGRETH, Forbes,  27 Oct 2009

Related Topics: AstraZeneca PLC,  Pfizer Inc.,  Novartis,  New York Stock Exchange

Hefty Side Effect For Kids On Antipsychotics

A new study is likely to add to the furious debate over the rapid rise in the prescription of heavy-duty antipsychotic drugs to children. It found that kids' weight balloons by 10 to 19 pounds in just the first three months on the drugs, often leading ...

From ROBERT LANGRETH, Forbes,  27 Oct 2009

Related Topics: Albert Einstein,  AstraZeneca PLC,  Johnson & Johnson,  Bristol-Myers Squibb,  American Medical Association

Wired Medicine's Silent Giant

Big name companies like General Electric, Siemens, McKesson and Cerner are rushing to profit from the push to install electronic patient records. But the hottest company in the electronic medical records industry is a secretive Wisconsin outfit called ...

From ROBERT LANGRETH, Forbes,  7 Oct 2009

Related Topics: Kaiser Permanente,  IBM,  General Electric,  University of Chicago,  Barack Obama

« Previous  |  Next »

Who is This?

Help us add to our database, by linking this writer their entry in Wikipedia or Source Watch, or by suggesting that we remove it from our index.

Suggest an Entry